Literature DB >> 33231567

Tumor necrosis factor superfamily 14 is critical for the development of renal fibrosis.

You Li1,2, Ming Tang1,3, Bo Han1, Shun Wu1, Shu-Jing Li3, Qian-Hui He3, Feng Xu2, Gui-Qing Li2, Kun Zhang1, Xu Cao1, Quan-You Zheng1, Jian Chen2, Di Yang2, Gui-Lian Xu2, Ke-Qin Zhang1,3.   

Abstract

OBJECTIVE: Tumor necrosis factor superfamily protein 14 (TNFSF14) was recently identified as a risk factor in some fibrosis diseases. However, the role of TNFSF14 in renal fibrosis pathogenesis remains unknown.
RESULTS: It was found that TNFSF14 levels were significantly increased both in UUO-induced renal fibrotic mice and in patients with fibrotic nephropathy, compared with those in controls. Accordingly, Tnfsf14 deficiency led to a marked reduction in renal fibrosis lesions and inflammatory cytokines expression in the UUO mice. Furthermore, the levels of Sphk1, a critical molecule that causes fibrotic nephropathy, were remarkably reduced in Tnfsf14 KO mice with UUO surgery. In vitro recombinant TNFSF14 administration markedly up-regulated the expression of Sphk1 of primary mouse renal tubular epithelial cells (mTECs).
CONCLUSION: TNFSF14 is a novel pro-fibrotic factor of renal fibrosis, for which TNFSF14 up-regulates Sphk1 expression, which may be the underlying mechanism of TNFSF14-mediated renal fibrosis.
METHODS: We investigated the effect of TNFSF14 on renal fibrosis and the relationship between TNFSF14 and pro-fibrotic factor sphingosine kinase 1 (Sphk1) by using the unilateral urethral obstruction (UUO)-induced mice renal fibrosis as a model and the specimen of patients with fibrosis nephropathy, by Masson trichrome staining, immunohistochemistry, qRT-PCR, and western blot analysis.

Entities:  

Keywords:  Sphk1; TNFSF14; renal fibrosis

Mesh:

Substances:

Year:  2020        PMID: 33231567      PMCID: PMC7803499          DOI: 10.18632/aging.104151

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  59 in total

Review 1.  Biomarkers for epithelial-mesenchymal transitions.

Authors:  Michael Zeisberg; Eric G Neilson
Journal:  J Clin Invest       Date:  2009-06-01       Impact factor: 14.808

2.  Prevalence of chronic kidney disease in China: a cross-sectional survey.

Authors:  Luxia Zhang; Fang Wang; Li Wang; Wenke Wang; Bicheng Liu; Jian Liu; Menghua Chen; Qiang He; Yunhua Liao; Xueqing Yu; Nan Chen; Jian-e Zhang; Zhao Hu; Fuyou Liu; Daqing Hong; Lijie Ma; Hong Liu; Xiaoling Zhou; Jianghua Chen; Ling Pan; Wei Chen; Weiming Wang; Xiaomei Li; Haiyan Wang
Journal:  Lancet       Date:  2012-03-03       Impact factor: 79.321

3.  Sphingosine Kinase 2 Deficiency Attenuates Kidney Fibrosis via IFN-γ.

Authors:  Amandeep Bajwa; Liping Huang; Elvira Kurmaeva; Hong Ye; Krishna R Dondeti; Piotr Chroscicki; Leah S Foley; Z Ayoade Balogun; Kyle J Alexander; Hojung Park; Kevin R Lynch; Diane L Rosin; Mark D Okusa
Journal:  J Am Soc Nephrol       Date:  2016-10-31       Impact factor: 10.121

4.  Sphingosine 1-phosphate (S1P)/S1P receptors are involved in human liver fibrosis by action on hepatic myofibroblasts motility.

Authors:  Changyong Li; Sujun Zheng; Hong You; Xihong Liu; Minghua Lin; Lin Yang; Liying Li
Journal:  J Hepatol       Date:  2010-10-31       Impact factor: 25.083

5.  Evidence that fibroblasts derive from epithelium during tissue fibrosis.

Authors:  Masayuki Iwano; David Plieth; Theodore M Danoff; Chengsen Xue; Hirokazu Okada; Eric G Neilson
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

6.  TLR4 activation mediates kidney ischemia/reperfusion injury.

Authors:  Huiling Wu; Gang Chen; Kate R Wyburn; Jianlin Yin; Patrick Bertolino; Josette M Eris; Stephen I Alexander; Alexandra F Sharland; Steven J Chadban
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

Review 7.  The origin of renal fibroblasts/myofibroblasts and the signals that trigger fibrosis.

Authors:  Yu Bo Yang Sun; Xinli Qu; Georgina Caruana; Jinhua Li
Journal:  Differentiation       Date:  2016-06-01       Impact factor: 3.880

8.  Curcumin ameliorates diabetic nephropathy by inhibiting the activation of the SphK1-S1P signaling pathway.

Authors:  Juan Huang; Kaipeng Huang; Tian Lan; Xi Xie; Xiaoyan Shen; Peiqing Liu; Heqing Huang
Journal:  Mol Cell Endocrinol       Date:  2012-11-02       Impact factor: 4.102

9.  Sphingosine 1-phosphate signaling contributes to cardiac inflammation, dysfunction, and remodeling following myocardial infarction.

Authors:  Fuyang Zhang; Yunlong Xia; Wenjuan Yan; Haoqiang Zhang; Fen Zhou; Shihao Zhao; Wei Wang; Di Zhu; Chao Xin; Yan Lee; Ling Zhang; Yuan He; Erhe Gao; Ling Tao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-11-20       Impact factor: 4.733

10.  The Tumor Necrosis Factor Superfamily Molecule LIGHT Promotes Keratinocyte Activity and Skin Fibrosis.

Authors:  Rana Herro; Ricardo Da S Antunes; Amelia R Aguilera; Koji Tamada; Michael Croft
Journal:  J Invest Dermatol       Date:  2015-03-19       Impact factor: 8.551

View more
  2 in total

1.  LIGHT deficiency attenuates acute kidney disease development in an in vivo experimental renal ischemia and reperfusion injury model.

Authors:  Quan-You Zheng; You Li; Shen-Ju Liang; Xi-Ming Chen; Ming Tang; Zheng-Sheng Rao; Gui-Qing Li; Jian-Li Feng; Yu Zhong; Jian Chen; Gui-Lian Xu; Ke-Qin Zhang
Journal:  Cell Death Discov       Date:  2022-09-26

2.  Distal Lung Microenvironment Triggers Release of Mediators Recognized as Potential Systemic Biomarkers for Idiopathic Pulmonary Fibrosis.

Authors:  Dimitrios Kalafatis; Anna Löfdahl; Per Näsman; Göran Dellgren; Åsa M Wheelock; Linda Elowsson Rendin; Magnus Sköld; Gunilla Westergren-Thorsson
Journal:  Int J Mol Sci       Date:  2021-12-14       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.